Arteris COO sells 9,219 shares in planned trade

Arteris, Inc. (AIP) reported that its Chief Operating Officer, Laurent R. Moll, sold a total of 9,219 shares of common stock on September 14, 2026 in open-market or private transactions.

Rhea-AI Filing Summary

Arteris, Inc. (AIP) reported that its Chief Operating Officer, Laurent R. Moll, sold a total of 9,219 shares of common stock on September 14, 2026 in open-market or private transactions. The sales were made under a Rule 10b5-1 trading plan adopted on March 12, 2026, with prices including a weighted average of $20.8409 for 9,119 shares and $21.75 for 100 shares.

Insider Trade Summary 10b5-1

Net Seller: 9,219 shares

Net Sell 2 txns

Insider Moll Laurent R

Role Chief Operating Officer

Sold 9,219 shs ($192K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2	9,119	$20.8409	$190K
Sale	Common Stock F1	100	$21.75	$2K

Holdings After Transaction: Common Stock — 212,478 shares (Direct)

Footnotes (2)

1. F1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 12, 2026.
2. F2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.55 to $21.43 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Total shares sold: 9,219 shares Primary sale: 9,119 shares at $20.8409 per share Additional sale: 100 shares at $21.75 per share +2 more

5 metrics

Total shares sold 9,219 shares Aggregate common stock sales by the Chief Operating Officer on September 14, 2026

Primary sale 9,119 shares at $20.8409 per share Weighted average sale price for a block of 9,119 shares on September 14, 2026

Additional sale 100 shares at $21.75 per share Separate common stock sale on September 14, 2026

Price range for weighted average sale $20.55–$21.43 per share Range of prices for trades included in the weighted average of $20.8409

Number of sale transactions 2 transactions Count of reported sales of common stock in this Form 4

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, open market or private transaction

3 terms

Rule 10b5-1 trading plan regulatory

"Transaction made pursuant to a 10b5-1 trading plan that was adopted"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"The price reported in Column 4 is a weighted average sale price."

open market or private transaction financial

"Sale in open market or private transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who from Arteris, Inc. (AIP) reported insider transactions in this Form 4?

The filing reports transactions by Laurent R. Moll, who serves as the Chief Operating Officer of Arteris, Inc. The report covers his trading activity in the company’s common stock on September 14, 2026.

How many Arteris (AIP) shares did the Chief Operating Officer sell?

The Chief Operating Officer sold a total of 9,219 shares of Arteris common stock, consisting of 9,119 shares in one transaction and 100 shares in a separate transaction, both on September 14, 2026.

At what prices were the Arteris (AIP) shares sold in this Form 4?

For 9,119 shares, the reported price is a weighted average sale price of $20.8409 per share, based on multiple trades between $20.55 and $21.43. A separate sale of 100 shares was reported at $21.75 per share.

Were the Arteris (AIP) insider sales made under a Rule 10b5-1 trading plan?

Yes. The filing states the transactions were made pursuant to a Rule 10b5-1 trading plan that the reporting person adopted on March 12, 2026, and the plan status box in the form is also checked.

Does the Form 4 state how many Arteris (AIP) shares the COO holds after these sales?

No. For both reported transactions, the field for shares owned following the transaction is left blank, so the filing does not state the Chief Operating Officer’s post-transaction holdings.

What type of transactions are reported for Arteris (AIP) in this Form 4?

Both entries are sales of common stock classified as open market or private transactions. There are no derivative exercises, grants, or gifts reported in this Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/15/2026 - 05:01 PM Accepted by SEC EDGAR 09/15/2026 - 05:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Moll Laurent R

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CALIFORNIA 95008

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/14/2026		S(1)		9,119	D	$20.8409(2)	212,578	D
Common Stock	09/14/2026		S(1)		100	D	$21.75	212,478	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 12, 2026.

2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.55 to $21.43 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Paul Alpern, as Attorney-in-Fact for Moll Laurent R	09/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)